prof. dr. Hans Van Vlierberghe
work address
De Pintelaan 185
9000 Gent
9000 Gent
ORCID iD
0000-0003-0647-92381 – 10 of 344
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
- Cu isotopic signature in blood serum of liver transplant patients: a follow-up study
- Enuresis nocturna: a malignant symptom?
- Successful treatment of HCV-associated B-cell non-Hodgkin lymphomas with direct-acting antiviral agents
- Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial
- Next-generation proteasome inhibitor oprozomib synergizes with modulators of the unfolded protein response to suppress hepatocellular carcinoma
- Longitudinal transient elastography measurements used in follow-up for patients with cystic fibrosis
- Laminin-332 sustains chemoresistance and quiescence as part of the human hepatic cancer stem cell niche
- Placental growth factor inhibition modulates the interplay between hypoxia and unfolded protein response in hepatocellular carcinoma
- Current status and perspectives of immune-based therapies for hepatocellular carcinoma
- Factors associated with 1,25 dihydroxyvitamin D3 concentrations in liver transplant recipients: a prospective observational longitudinal study